Expanding capacities for cancer therapy

As a long-time partner in the battle against cancer, we at Heraeus Precious Metals business line Pharmaceutical Ingredients have made a significant investment into our new state-of-the-art production line for platinum containing highly active pharmaceutical ingredients (hAPIs). Take a sneak peek of our new facilities in our video.

"My hAPI team is your road to success."

Dr. Marcus Hannakam

"Score with our know-how and services."

Dr. Gabi Ohlendorf

"Comprehensive regulatory support is my passion."

Ines zum Hebel

"Our R & D experts - your asset in all CMC phases."

Dr. Holger Rauter

Pharmaceutical Ingredients

Cancer cases are globally on the rise, causing an increasing demand for their treatment. Highly Potent Active Pharmaceutical Ingredients (hAPIs) are key compounds for use in cancer chemotherapy and are of great relevance especially in combination therapies.
Heraeus Pharmaceutical Ingredients is specialized in the production of generic APIs (Active Pharmaceutical Ingredients) as well as the exclusive synthesis of cytotoxic compounds from the research stage to registration to market launch.

Products and Services

Generic hAPIs

Generic hAPIs

The high purity of our active pharmaceutical ingredients guarantees our customers effective processes and consistently top quality for their products. Continual further development of our knowledge enables them to maintain compliance with changing regulations and ensures a long-term drug supply.

CDMO

Contract Manufacturing of Highly Potent APIs (CDMO)

Many highly active ingredients require special, which compels manufacturers to take appropriate protective measures. Heraeus with its diverse experience in chemistry, processes and the appropriate equipment is a partner fully dedicated to the manufacturing of hAPIs.

Custom Manufacturing

Cancer cases are steadily on the rise across the globe. Highly active pharmaceutical ingredients (hAPIs) are the key compounds and most relevant to combination therapies in particular. Both developing new active ingredients and optimizing lab syntheses for mass production require the profound knowledge of experts. Moreover, hAPIs have to be handled in high-containment facilities with extreme care.

Heraeus has the appropriate equipment and extensive experience in dealing with such challenging molecules. We support our customers in the exclusive synthesis of cytotoxic compounds from the research stage to registration and market launch. With these comprehensive services, customers are free to focus on their core business and to transform their innovative ideas into commercial products.

More than 40 years of expertise in the field of cytotoxic hAPIs is the foundation of our exclusive contract development and manufacturing services (CDMO). Therefore,

  • Heraeus' high-containment systems (OEL < 10 ng/m3) ensure the highest technological standard.
  • Scientists and experts contribute extensive knowledge and experience to each project.
  • Contract manufacturing includes batches from gram to fully commercial scale.
  • With comprehensive GMP documentation and outstanding global regulatory support we offer the full-service package.
  • Heraeus strictly protects customers’ IP.

With our comprehensive knowledge in process chemistry and project management, we always create tailor-made offers to you as our clients and guarantee time-efficient and cost-effective solutions for any challenges you may face.

Quality Competence

Quality Competence

Extensive analytical capabilities, qualitiy assurance and the full reliability of a partner are extremely important to pharmaceutical clients worldwide. Heraeus constantly secures the quality of active pharmaceutical ingredients, strictly follows international regulations and prepares and maintains all documentation for initial and existing registrations worldwide.

Contact

Dr. Gabi Ohlendorf
Sales

Dr. Gabi Ohlendorf

Global Head of Marketing & Sales, Pharmaceutical Ingredients
Sales

Dr. Felix Held

Project Manager New Business Pharmaceutical Ingredients